Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life

Autor: Marina Sánchez-Agesta, Cristina Rabasco, María J. Soler, Amir Shabaka, Elisabeth Canllavi, Saulo J. Fernández, Juan M. Cazorla, Esperanza López-Rubio, Ana Romera, Sergio Barroso, Ana Huerta, Leonardo Calle, Milagros Sierra, Patricia Domínguez-Torres, Manuela Moreno-Ramírez, Sara Afonso, Victoria Mascarós, Armando Coca, Mario Espinosa, Spanish Group for the Study of Glomerular Diseases (GLOSEN)

Publikováno v: Frontiers in Medicine, Vol 9 (2022)

IntroductionAnti-glomerular basement membrane (anti-GBM) disease is a severe entity with few therapeutic options including plasma exchange and immunosuppressive agents. The aim of this study was to analyze the clinical and pathological features that

Externí odkaz: https://doaj.org/article/4a8e37559a514cee8e8cade309709f69

Predictores de eventos clínicos en una cohorte de pacientes con enfermedad de Fabry en tratamiento sustitutivo enzimático

Autor: Goicoechea, Marian, Gomez Preciado, Francisco, Benito, Silvia, Torras Ambròs, Joan, Torra, Roser, Huerta, Ana, Restrepo, Alejandra, Ugalde, Jessica, Astudillo, Daniela Estefania, Agraz, Irene, Lopez Mendoza, Manuel, Arriba, Gabriel de, Corchete, Elena, Quiroga, Borja, Gutierrez, Maria Jose, Martin Conde, Maria Luisa, Lopes, Vanessa, Ramos, Carmela, Mendez, Irene, Cao, Mercedes, Dominguez, Fernando, Ortiz, Alberto, Spanish Group for the Study of Glomerular Diseases (GLOSEN)

Publikováno v: Repositorio Abierto de la UdL
Universitad de Lleida
Nefrología (English Edition), Vol 41, Iss 6, Pp 652-660 (2021)
Scientia
Dipòsit Digital de la UB
Universidad de Barcelona
Nefrología, Vol 41, Iss 6, Pp 652-660 (2021)

Enfermedad de Fabry; Enfermedad renal crónica; Tratamiento enzimático sustitutivo Fabry disease; Chronic kidney disease; Enzyme replacement therapy Malaltia de Fabry; Malaltia renal crònica; Tractament enzimàtic substitutiu Fabry disease may be t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efbf2142ebd5865ea7a50f5b27fb394
https://doi.org/10.1016/j.nefro.2021.01.002

Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis

Autor: Rodríguez, Eva, Latzke, Belén, Sierra Carpio, Milagros, Romera, Ana María, Siedel, Diego, Agraz, Irene, Soler, María José, García Carro, Clara, Draibe, Juliana, Prada, Francisco José de la, Villacorta, Javier, Buxeda, Anna, Sierra Ochoa, Adriana, Lozano, Inés, Durán, Xavier, Barrios Barrera, Clara, Pascual, Julio (Pascual Santos), Spanish Group for the Study of Glomerular Diseases (GLOSEN)

Background: The value of myeloperoxidase and proteinase 3 antibodies titers in the assessment of renal disease activity and flare prediction in patients with ANCA-associated-vasculitis (AAV) is not well-known. Methods: Retrospective study including 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1610::3ac41e4a86356c9c1b6f3c2b1cfb39b0
http://hdl.handle.net/10230/48101

Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

Autor: Cavero, Teresa, Arjona, Emilia, Soto, Karina, Caravaca-Fontán, Fernando, Rabasco, Cristina, Bravo, Luis, de la Cerda, Francisco, Martín, Nadia, Blasco, Miquel, Ávila, Ana, Huerta, Ana, Cabello, Virginia, Jarque, Ana, Alcázar, Concepción, Fulladosa, Xavier, Carbayo, Javier, Anaya, Sara, Cobelo, Carmen, Ramos, Natalia, Iglesias, Elena, Baltar, José, Martínez-Gallardo, Rocío, Pérez, Lourdes, Morales, Enrique, González, Roberto, Macía, Manuel, Draibe, Juliana, Pallardó, Luis, Quintana, Luis F, Espinosa, Mario, Barros, Xoana, Pereira, Fernando, Cao, Mercedes, Moreno, Juan Antonio, Rodríguez de Córdoba, Santiago, Praga, Manuel, Spanish Group for the Study of Glomerular Diseases (GLOSEN)

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname

Malignant hypertension is listed among the causes of secondary thrombotic microangiopathy (TMA), but pathogenic mutations in complement genes have been reported in patients with hypertension-induced TMA. Here we investigated the frequency and severit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92799c84664f2aa73a1d86f4f1cd028
https://pubmed.ncbi.nlm.nih.gov/31648699

Risk factors for non-diabetic renal disease in diabetic patients.

Autor: Bermejo S; Nephrology Department, Hospital del Mar, Barcelona, Spain.; Nephrology Department, Fundació Althaia, Manresa, Spain., González E; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain., López-Revuelta K; Nephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Ibernon M; Nephrology Department, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain., López D; Nephrology Department, Clínica Universitaria de Navarra, Pamplona, Spain., Martín-Gómez A; Nephrology Department, Hospital de Poniente, Almería, Spain., Garcia-Osuna R; Nephrology Department, Hospital de Palamós, Girona, Spain., Linares T; Nephrology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Díaz M; Nephrology Department, Fundació Puigvert, Barcelona, Spain., Martín N; Nephrology Department, Hospital Universitari Josep Trueta, Girona, Spain., Barros X; Nephrology Department, Hospital Universitari Josep Trueta, Girona, Spain., Marco H; Nephrology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Navarro MI; Nephrology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Esparza N; Nephrology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain., Elias S; Nephrology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Coloma A; Nephrology Department, Hospital San Pedro, Logroño, Spain., Robles NR; Nephrology Department, Hospital Infanta Cristina, Badajoz, Spain., Agraz I; Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain., Poch E; Nephrology Department, Hospital Clínic, Barcelona, Spain.; IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Rodas L; Nephrology Department, Hospital Clínic, Barcelona, Spain.; IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Lozano V; Nephrology Department, Hospital Clínic, Barcelona, Spain.; IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Fernández B; Nephrology Department, Fundación Jiménez Díaz, Madrid, Spain., Hernández E; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain., Martínez MI; Nephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Stanescu RI; Nephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Moirón JP; Nephrology Department, Clínica Universitaria de Navarra, Pamplona, Spain., García N; Nephrology Department, Clínica Universitaria de Navarra, Pamplona, Spain., Goicoechea M; Nephrology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Calero F; Nephrology Department, Fundació Puigvert, Barcelona, Spain., Bonet J; Nephrology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Galceran JM; Nephrology Department, Fundació Althaia, Manresa, Spain., Liaño F; Nephrology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Pascual J; Nephrology Department, Hospital del Mar, Barcelona, Spain., Praga M; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain., Fulladosa X; Nephrology Department, Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; Spanish Group for the Study of Glomerular Diseases (GLOSEN), Grup de Treball de Malalties Glomerulars de la Societat Catalana de. Nefrologia (GlomCAT), and Grupo Español de Estudio de Nefropatía Diabética (GEENDIAB)., Soler MJ; Nephrology Department, Hospital del Mar, Barcelona, Spain.; Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain.

Publikováno v: Clinical kidney journal [Clin Kidney J] 2020 Jan 03; Vol. 13 (3), pp. 380-388. Date of Electronic Publication: 2020 Jan 03 (Print Publication: 2020).